ruxolitinib,momelotinib
novartis,incyte,sierra oncology
['bet', '#mpn', 'mpnsm']
mpn patients can live longer, they can live better (better qol) or both. at this point other surrogate endpoints remain experimental and not yet validated. #mpnsm #ash22 
Executive Director- Mays Cancer Center at UT Health San Antonio MD Anderson. Focus- MPNs #MPNSM, Cancer, Health Equity, QoL (Twitter posts = personal opinion)